Yet more evidence has just come to light about the dangers of the painkiller Vioxx (rofecoxib), which was withdrawn from the market in 2004 after it was found to cause heart failure. 

Apparently it was doing the very same thing to cancer patients, who were being given the drug after surgery.

A new study among 2,327 patients with colon rectal cancer found that Vioxx nearly trebled the chances of cardiovascular problems, and usually within 14 days of first starting the drug.

Although the trial was stopped in September, 2004 when Vioxx was taken off the market, researchers in the VICTOR (Vioxx in Colorectal Cancer Therapy) study decided to continue monitoring the health of the patients for the following two years.

The trend continued, and another six patients who were given Vioxx developed cardiovascular problems.



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Merck to pay $830 million to settle investors’ Vioxx...

Merck announced Friday it will pay $830 million to settle investor complaints accusing it of committing...

Merck to pay nearly $1 billion for illegal marketing...

American pharmaceutical company Merck, Sharp & Dohme has agreed to pay $950 million to resolve criminal...

Merck paying more than 3,100 vioxx death claims

Merck & Co. is paying claims by the families of more than 3,100 users of its Vioxx painkiller who...

Settlement limits insurers' claims in Vioxx deal

TRENTON, N.J. (AP) -- Former Vioxx users getting part of a $4.85 billion settlement ending most personal...

Persistence pays in Vioxx litigation

Plaintiffs get close to $5B, but Merck could have done a lot worse. Attorneys who spent nearly one year...

Merck will fund Vioxx settlement in August

Pharmaceutical company Merck says it will start cutting checks next month for former users of its...

Respectful, understanding, efficient and compassionate

Beasley Allen is one of the most professional organizations I have ever had the pleasure of working with. They are respectful, understanding, efficient, and above all compassionate. They take the best care of their clients in every way possible. They keep us informed and aware of things involved in their clients cases. Their counsel is stellar in the industry. I would highly recommend them to others in their time of need and I have done so.

—Chad